Figure S1 from Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer

<p>In vitro xevinapant combination with CRT increases MOC1 tumour cell death but not in mEER.</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Charleen Chan Wah Hak (22698167) (author)
Outros autores:	Emmanuel C. Patin (22698170) (author), Anton Patrikeev (22698173) (author), Annalisa Nicastri (22698176) (author), Zuza Kozik (22698179) (author), Holly Baldock (22698182) (author), Joan N. Kyula-Currie (15016394) (author), Victoria Roulstone (20823102) (author), Amarin Wongariyapak (22698185) (author), Valentina Gifford (22698188) (author), Tencho Tenev (22698191) (author), Elizabeth S. Appleton (22698194) (author), Lisa C. Hubbard (22698197) (author), Shane Foo (22698200) (author), Malin Pedersen (22698203) (author), Jyoti S. Choudhary (17408556) (author), Masahiro Ono (22698206) (author), Alan A. Melcher (20823117) (author), Antonio Rullan (14941920) (author), Kevin J. Harrington (17801531) (author)
Publicado:	2025
Subjects:	Cancer Tumor Biology Therapeutic Research and Development Immuno-oncology Methods and Technology Animal Models Of Cancer Head, Neck & Oral Cancers Immunology Immunomodulation Preclinical Models Radiation Oncology Combined modality therapies Tumor Microenvironment
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares